A novel coronavirus outbreak of global health concern by Wang, C, Horby, PW, Hayden, FG, Gao, GF

COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference by McKimm-Breschkin, JL, Hay, AJ, Cao, B, Cox, RJ, Dunning, J, Moen, AC, Olson, D, Pizzorno, A, Hayden, FG

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis by Xu, J, Huang, C, Fan, G, Liu, Z, Shang, L, Zhou, F, Wang, Y, Yu, J, Yang, L, Xie, K, Huang, Z, Huang, L, Gu, X, Li, H, Zhang, Y, Wang, Y, Hayden, FG, Horby, PW, Cao, B, Wang, C

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, m... by Monaghan, K, Wang, Y, Zhou, F, Zhang, D, Zhao, J, Du, R, Hu, Y, Cheng, Z, Gao, L, Jin, Y, Luo, G, Fu, S, Lu, Q, Du, G, Wang, K, Lu, Y, Fan, G, Zhang, Y, Liu, Y, Ruan, S, Liu, W, Jaki. T, Hayden, FG, Horby, PW, Cao, B, Wang, C

Effect of ribavirin and interferon on the outcome of critically ill patients with mers by Arabi, YM, Shalhoub, S, Omari, A, Mandourah, Y, Al-Hameed, F, Sindi, A, Alraddadi, B, Motairi, A, Khatib, K, Mommin, AA, Qushmaq, IA, Mady, A, Solaiman, O, Aithan, A, Balkhy, HH, Al-Raddadi, R, Rajab, A, Mekhlafi, GA, Harthy, A, Kharaba, A, Al-Jabbary, A, Pinto, R, Sadat, M, Mutairi, H, Qasim, E, Jose, J, Deeb, AM, Merson, L, Hayden, FG, Fowler, R, Aldawood, AS

Open source clinical science for emerging infections by Dunning, JW, Merson, L, Rohde, GG, Gao, Z, Semple, MG, Tran, D, Gordon, A, Olliaro, PL, Khoo, SH, Bruzzone, R, Horby, P, Cobb, JP, Longuere, K-S, Kellam, P, Nichol, A, Brett, S, Everett, D, Walsh, TS, Hien, T-T, Yu, H, Zambon, M, Ruiz-Palacios, G, Lang, T, Akhvlediani, T, Hayden, FG, Marshall, J, Webb, S, Angus, DC, Shindo, N, van der Werf, S, Openshaw, PJ, Farrar, J, Carson, G, Baillie, JK

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza by Wang, Y, Zhong, W, Salam, A, Tarning, J, Zhan, Q, Huang, J-A, Weng, H, Bai, C, Ren, Y, Yamada, K, Wang, D, Guo, Q, Fang, Q, Tsutomu, S, Zou, X, Li, H, Gillesen, A, Castle, L, Chen, C, Li, H, Zhen, J, Lu, B, Duan, J, Guo, L, Jiang, J, Cao, R, Fan, G, Li, J, Hayden, FG, Wang, C, Horby, P, Cao, B

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. by Wang, Y, Zhang, D, Du, G, Du, R, Zhao, J, Jin, Y, Fu, S, Gao, L, Cheng, Z, Lu, Q, Hu, Y, Luo, G, Wang, K, Lu, Y, Li, H, Wang, S, Ruan, S, Yang, C, Mei, C, Wang, Y, Ding, D, Wu, F, Tang, X, Ye, X, Ye, Y, Liu, B, Yang, J, Yin, W, Wang, A, Fan, G, Zhou, F, Liu, Z, Gu, X, Xu, J, Shang, L, Zhang, Y, Cao, L, Guo, T, Wan, Y, Qin, H, Jiang, Y, Jaki, T, Hayden, FG, Horby, PW, Cao, B, Wang, C